Moreover, it has been reported that miR‐200a is related to the occurrence and development of endometrial cancer, breast cancer, and esophageal cancer by targeting genes, such as PTEN, EPHA2, and CRMP‐1. This evidence concerns the gene CRMP1 and breast carcinoma.